# –ö—Ä–∞—Ç–∫–æ–µ —Ä–µ–∑—é–º–µ: –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–∞—è –≤–∞–ª–∏–¥–∞—Ü–∏—è EGNN –º–æ–¥–µ–ª–∏

## –¶–µ–ª—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è

–í–∞–ª–∏–¥–∞—Ü–∏—è Equivariant Graph Neural Network (EGNN) –º–æ–¥–µ–ª–∏ –Ω–∞ —Ä–µ–∞–ª—å–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö HOMO-LUMO Gap –¥–ª—è –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤.

## –ö–ª—é—á–µ–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã

### üéØ –û–±—â–∞—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å
- **MAE**: 0.373 eV (Domain Shift Factor: 4.9x –æ—Ç QM9 baseline)
- **R¬≤**: 0.505 (—É–º–µ—Ä–µ–Ω–Ω–∞—è –∫–æ—Ä—Ä–µ–ª—è—Ü–∏—è)
- **–°—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∞—è –∑–Ω–∞—á–∏–º–æ—Å—Ç—å**: p < 1e-10 (–≤—ã—Å–æ–∫–æ –∑–Ω–∞—á–∏–º–æ)
- **–ú–æ–ª–µ–∫—É–ª –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏**: 65 –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤

### üìä –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —Ä–∞–∑–º–µ—Ä–∞–º –º–æ–ª–µ–∫—É–ª

| –†–∞–∑–º–µ—Ä –º–æ–ª–µ–∫—É–ª | –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ | MAE (eV) | R¬≤ | –ö–∞—á–µ—Å—Ç–≤–æ |
|----------------|------------|----------|----|---------| 
| –ú–∞–ª—ã–µ (14-28 –∞—Ç–æ–º–æ–≤) | 8 | **0.112** | **0.969** | –û—Ç–ª–∏—á–Ω–æ–µ |
| –°—Ä–µ–¥–Ω–∏–µ (31-58 –∞—Ç–æ–º–æ–≤) | 19 | **0.197** | **0.890** | –•–æ—Ä–æ—à–µ–µ |
| –ë–æ–ª—å—à–∏–µ (61-90 –∞—Ç–æ–º–æ–≤) | 11 | 0.308 | 0.623 | –£–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω–æ–µ |
| –û—á–µ–Ω—å –±–æ–ª—å—à–∏–µ (102-185 –∞—Ç–æ–º–æ–≤) | 16 | 0.331 | 0.082 | –ü–ª–æ—Ö–æ–µ |
| –ì–∏–≥–∞–Ω—Ç—Å–∫–∏–µ (201-361 –∞—Ç–æ–º–æ–≤) | 11 | 0.992 | 0.021 | –û—á–µ–Ω—å –ø–ª–æ—Ö–æ–µ |

### üß¨ –õ—É—á—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ –∫–ª–∞—Å—Å–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤

1. **Nitroimidazole** (metronidazole): 1.1% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–∞—è –æ—à–∏–±–∫–∞
2. **Sulfonamide** (sulfisoxazole): 0.7% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–∞—è –æ—à–∏–±–∫–∞  
3. **Antitubercular** (isoniazid): 1.6% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–∞—è –æ—à–∏–±–∫–∞

### ‚ö†Ô∏è –ü—Ä–æ–±–ª–µ–º–Ω—ã–µ –æ–±–ª–∞—Å—Ç–∏

1. **–ö—Ä—É–ø–Ω—ã–µ –ø–µ–ø—Ç–∏–¥—ã**: MAE –¥–æ 0.992 eV –¥–ª—è –º–æ–ª–µ–∫—É–ª >200 –∞—Ç–æ–º–æ–≤
2. **–ü–æ–ª–∏–ø–µ–ø—Ç–∏–¥–Ω—ã–µ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏**: –û—Å–æ–±–µ–Ω–Ω–æ —Å–ª–æ–∂–Ω—ã –¥–ª—è –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏—è
3. **Domain shift**: –†–∞—Å—Ç–µ—Ç —Å —Ä–∞–∑–º–µ—Ä–æ–º –º–æ–ª–µ–∫—É–ª (1.47x ‚Üí 13.05x)

## –ù–∞—É—á–Ω–∞—è –∑–Ω–∞—á–∏–º–æ—Å—Ç—å

- **–ü–µ—Ä–≤–∞—è –≤–∞–ª–∏–¥–∞—Ü–∏—è** EGNN –Ω–∞ —Ä–µ–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö
- **–°—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã** —Å –≤—ã—Å–æ–∫–æ–π –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ—Å—Ç—å—é
- **–°–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –∞–Ω–∞–ª–∏–∑** –≤–ª–∏—è–Ω–∏—è —Ä–∞–∑–º–µ—Ä–∞ –º–æ–ª–µ–∫—É–ª –Ω–∞ —Ç–æ—á–Ω–æ—Å—Ç—å
- **–ú–µ—Ç–æ–¥–æ–ª–æ–≥–∏—è –æ—Ü–µ–Ω–∫–∏** domain shift –¥–ª—è –±–∏–æ–º–æ–ª–µ–∫—É–ª

## –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏

### ‚úÖ –†–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è:
- –ú–∞–ª—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ (< 60 –∞—Ç–æ–º–æ–≤)
- –ü—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π
- –°—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω–æ-–∞–∫—Ç–∏–≤–Ω—ã—Ö —Å–≤—è–∑–µ–π

### ‚ùå –ù–µ —Ä–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –¥–ª—è:
- –ö—Ä—É–ø–Ω—ã—Ö –ø–µ–ø—Ç–∏–¥–Ω—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ (> 100 –∞—Ç–æ–º–æ–≤)
- –¢–æ—á–Ω—ã—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–π –±–µ–∑ –∫–∞–ª–∏–±—Ä–æ–≤–∫–∏
- –ú–æ–ª–µ–∫—É–ª, —Å–∏–ª—å–Ω–æ –æ—Ç–ª–∏—á–∞—é—â–∏—Ö—Å—è –æ—Ç QM9 –æ–±—É—á–∞—é—â–µ–≥–æ –Ω–∞–±–æ—Ä–∞

## –í—ã–≤–æ–¥—ã

EGNN –º–æ–¥–µ–ª—å –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç **—Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—É—é –∫–æ—Ä—Ä–µ–ª—è—Ü–∏—é** —Å —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏ (r = 0.711, p < 1e-10), –Ω–æ —Ç—Ä–µ–±—É–µ—Ç **—Å–ø–µ—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –¥–ª—è –±–∏–æ–º–æ–ª–µ–∫—É–ª**. –ú–æ–¥–µ–ª—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞ –¥–ª—è –º–∞–ª—ã—Ö –∏ —Å—Ä–µ–¥–Ω–∏—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤, –Ω–æ –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ —É–ª—É—á—à–µ–Ω–∏—è—Ö –¥–ª—è –∫—Ä—É–ø–Ω—ã—Ö –ø–µ–ø—Ç–∏–¥–Ω—ã—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä.

---

*–ü–æ–ª–Ω—ã–π –æ—Ç—á–µ—Ç: experimental_validation_report.md*  
*–î–∞–Ω–Ω—ã–µ –∏ –≤–∏–∑—É–∞–ª–∏–∑–∞—Ü–∏–∏: results/experimental_gap_validation/*